uric acid has been researched along with favipiravir in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Anzai, N; Mishima, E; Miyazaki, M | 1 |
| Hase, R; Ishida, K; Kurata, R; Kurita, T; Mito, H; Muranaka, E | 1 |
| Başaran, NÇ; İnkaya, AÇ; Kara, E; Şahin, TK; Ünal, S; Uyaroğlu, OA; Uzun, Ö | 1 |
| Chiaki, T; Kinjo, T; Kondo, D; Kubota, K; Minami, S; Moriiwa, Y; Morikawa, G; Okazawa, K; Takanashi, Y; Yanagida, A | 1 |
| Doi, Y; Iwasaki, H; Koseki, T; Mizuno, T; Nakajima, K; Takahashi, K; Yamada, S | 1 |
| Hanai, Y; Ishii, Y; Mabuchi, T; Matsuo, K; Miyazaki, T; Nishimura, K; Nishizawa, K; Ohashi, H; Tateda, K; Uekusa, S; Yoshio, T; Yoshizawa, S | 1 |
1 review(s) available for uric acid and favipiravir
| Article | Year |
|---|---|
Uric Acid Elevation by Favipiravir, an Antiviral Drug.
Topics: Aldehyde Oxidase; Amides; Antiviral Agents; Biotransformation; Coronavirus Infections; COVID-19; Drug Interactions; Humans; Hyperuricemia; Kidney; Kidney Diseases; Molecular Structure; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Pandemics; Pneumonia, Viral; Pyrazines; Uric Acid; Xanthine Oxidase | 2020 |
5 other study(ies) available for uric acid and favipiravir
| Article | Year |
|---|---|
Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019.
Topics: Adult; Amides; Antiviral Agents; Arthritis, Gouty; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hyperuricemia; Lung; Male; Pandemics; Pneumonia, Viral; Pyrazines; SARS-CoV-2; Uric Acid | 2020 |
Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients.
Topics: Biomarkers; COVID-19 Drug Treatment; Humans; Hypoxanthine Phosphoribosyltransferase; Influenza, Human; SARS-CoV-2; Uric Acid | 2021 |
Elevated blood favipiravir levels are inversely associated with ferritin levels and induce the elevation of uric acid levels in COVID-19 treatment: A retrospective single-center study.
Topics: Amides; Antiviral Agents; COVID-19 Drug Treatment; Ferritins; Humans; Pyrazines; Retrospective Studies; SARS-CoV-2; Uric Acid | 2022 |
Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients.
Topics: Amides; COVID-19; Humans; Hyperuricemia; Pyrazines; SARS-CoV-2; Uric Acid | 2022 |
Evaluation of risk factors for uric acid elevation in COVID-19 patients treated with favipiravir.
Topics: Amides; Antiviral Agents; COVID-19 Drug Treatment; Humans; Pyrazines; Retrospective Studies; Risk Factors; SARS-CoV-2; Treatment Outcome; Uric Acid | 2022 |